Brexpiprazole CAS 913611-97-9 Kuchena >99.0% (HPLC) API Factory

Tsanangudzo Pfupi

Kemikari Zita: Brexpiprazole

CAS: 913611-97-9

Kuchena:> 99.0% (HPLC)

Chitarisiko: Muchena kana Kunze-Ichena Crystalline Powder

API High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Tumira email kwatiri

Product Detail

Product Tags

Tsanangudzo:

Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-imwe CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3

Chemical Properties:

Chemical Name	Brexpiprazole
Mashoko anoreva zvakafanana	OPC-34712;7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-imwe
Nhamba yeCAS	913611-97-9
Nhamba yeCAT	RF-PI1982
Stock Status	MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula	C25H27N3O2S
Molecular Weight	433.57
Density	1.245±0.060 g/cm3
Brand	Ruifu Chemical

Zvinotsanangurwa:

Item	Zvinotsanangurwa
Chitarisiko	Ichena kana Isina-White Crystalline Powder
Identification	Kubva IR
RT	Under chirality inofanira kuenderana
Chloride	Inopa maitiro e chloride
Mvura	3.0%~4.5%
Melting Point	198.0 ~ 202.0℃
Residue paIgnition	<0.20%
Heavy Metals	≤10ppm
Related Substances
Kusachena Kwemunhu	<0.50%
Zvose Zvisina Kuchena	<1.00%
EE	>99.0%
Kuchena / Analysis Method	> 99.0% (HPLC, pane yakaoma)
Test Standard	Enterprise Standard
Usage	API

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro

Zvakanakira:

FAQ:

Application:

Brexpiprazole (CAS: 913611-97-9) mumiriri wezvinodhaka anobatsira mukurapa nekudzivirira kukanganiswa kwepfungwa kunosanganisira CNS kusagadzikana.Brexpiprazole inova antipsychotic drug iyo inoshanda se serotonin ® dopamine chiitiko modulator uye yakaratidza kushanda seyakagadziriswa kurapa kune varwere vane hukuru hwekuora mwoyo kusagadzikana (MDD).Brexpiprazole inoratidzira yakasarudzika pharmacological profile, ichiita sechikamu agonist cheserotonin 5-HT1A uye dopamine D2 receptors uye seanopikisa akazara we5-HT2A uye noradrenaline α1B / 2C receptors, ine yakafanana subnanomolar inosunga hukama.Brexpiprazole yakagadzirwa naOtsuka naLundbeck, yakatenderwa muna 2015 neFDA pakurapa schizophrenia uye senzira yekuwedzera yekuora mwoyo.Brexpiprazole inoonekwa zvakanyanya semutsivi weOtsuka's antipsychotic drug aripiprazole (zita rekutengesa Abilify) ane patent yakapera muna Nyamavhuvhu 2014.